Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study

Liang Zhang; Na Li; Ling-Li Cui; Fu-Shan Xue; Zhi-Jun Zhu

doi:10.12659/AOT.933354

15 October 2021 : Original article

Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study

Liang Zhang^1ABCDEF, Na Li^1BEF, Ling-Li Cui^1BF, Fu-Shan Xue^1ADFG*, Zhi-Jun Zhu^234ADFG

DOI: 10.12659/AOT.933354

Ann Transplant 2021; 26:e933354

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Intraoperative use of dexmedetomidine is associated with a reduced incidence of moderate-to-severe hepatic ischemia-reperfusion injury in pediatric deceased liver transplantation. DEX – dexmedetomidine; HIRI – hepatic ischemia-reperfusion injury. GraphPad Prism 5 (GraphPad Software, Inc., San Diego, CA, USA).

Back to the Article

Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study

Your Privacy